Carb-X investment gives Snipr Biome validation before going to clinic

Snipr Biome has received a capital injection from antibiotics alliance Carb-X totaling up to USD 10.2m. CEO Christian Grøndahl thinks this will aid the company in its upcoming financing round.
Snipr Biome CEO Christian Grøndahl | Photo: EY / PR
Snipr Biome CEO Christian Grøndahl | Photo: EY / PR
BY ELIZABETH MØNSTED JOHANSEN, TRANSLATED BY NIELSINE NIELSEN

Snipr Biome is delighted with the money recently placed in its account by global antibiotics alliance Carb-X, although the company was already keeping its head above water.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading